NCT03637049 - Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

August 9, 2018

Study Completion Date

August 22, 2018

Conditions

Healthy

Interventions

DRUG

PBI-4050 and midazolam

A single oral dose of midazolam (1 mL of 2mg/mL syrup) will be given to all subjects in Period 1 and on Day 5 of Period 2. 1200 mg of PBI-4050 (3 X 400 mg tablets) will be administered for 5 days (Day 1 to Day 5) of Period 2 and a single dose of midazolam (1 mL of 2mg/mL) on Day 5.

Trial Locations (1)

85283

Celerion, Tempe